home.aspx
 
EVENTS

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...

Aratana Therapeutics Inc.

SHARESHARESHARE
Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for cats and dogs. Aratana is a fast-growing company headquartered in the greater Kansas City area focused on delivering safe and effective therapeutics that elevate the standard of care in veterinary medicine. As a pioneer in pet therapeutics, Aratana’s goal is to work with companion animal veterinarians to bring new therapeutics to market that support the needs of pets and their owners.
SHARESHARESHARE

RELATED NEWS


Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. The trial will test the efficacy of KAF156 in combination with a new, improved formulation of the existing antimalarial lumefantrine. The first trial centre is operational in Mali and will be followed by sixteen additional centers across a total of nine countries in Africa and Asia over the n...

READ MORE

A subsidiary of UPS has gained regulatory clearance allowing it to expand a medical drone delivery service to support hospitals across the US. UPS Flight Forward said earlier this month it has received the US government certification to operate a drone airline. Immediately after the US Federal Aviation Administration awarded the company a ‘Part 135 Standard’ certification the UPS subsidiary immediately launched the first drone delivery flight. The flight used a Matternet M2 quadcopte...

READ MORE

There are millions of clinicians fighting on the front lines of the obesity epidemic every day, but there doesn’t seem to be a winning strategy. The population of seriously overweight people around the world is rising and will soon reach one billion. At the University of Wisconsin-Madison researchers may have a technological, drug-free solution to the problem for many of those afflicted.
The team developed a tiny battery-free implant that’s only about a centimeter across, whic...


READ MORE

Astellas Pharma has announced the initiation and dosing of the first patient in its SKYLIGHT1 Phase III pivotal trial for fezolinetant. The investigational oral, non-hormonal compound is being studied for the treatment of moderate-to-severe menopause related vasomotor symptoms VMS, such as hot flashes and night sweats. The first trials of the programme will evaluate the efficacy and safety of 30 and 45 mg once-daily (QD) doses of fezolinetant in reducing VMS frequency and severity. “There ...

READ MORE

Samsung has followed the example of Apple and launched a smartwatch with a focus on improving the wearer’s health. But unlike its rival, which has marketed a watch that provides an electrocardiogram function, Samsung has opted to provide a feature that measures a wearer’s blood pressure. Starting on 15 March, users will be able to download My BP Lab, a research app jointly developed with the University of California, San Francisco to their Galaxy Watch Active. Samsung said the app wi...

READ MORE

Big Data, biology and genomics have led to understanding how to create a new drug from an old one. An algorithm has been used to analyse the molecular properties of an existing drug used for treat some tumors and found that it also works against metabolic syndrome. The research study, published by Nature Communications, was led by the University of Trento. It shows how the approach can help 'drug repositioning', which is a new frontier of pharmacological research that uses new indication...

READ MORE

EVENTS

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...